乙肝保健网:为广大乙肝患者公益分享健康注意事项
乙肝在研新药:REP 2139联合聚乙二醇干扰素α治疗HBV,45%的患者可获得乙肝的功能性治愈
阅读全文2020-12-15
乙肝在研新药:F351对慢乙肝相关肝纤维化Phase II 期临床结果积极
阅读全文2020-08-20
DicernaPharmaceuticals在研乙肝新药RG6346(DCR
阅读全文2020-08-08
DicernaPharmaceuticals在研乙肝新药RG6346(DCR
阅读全文2020-08-08
DicernaPharmaceuticals在研乙肝新药RG6346(DCR
阅读全文2020-08-08
DicernaPharmaceuticals在研乙肝新药RG6346(DCR
阅读全文2020-08-08
阅读全文2020-06-28
罗氏在研乙肝新药:RO7020531和RO7049389联合用药已获得药监局批准
阅读全文2020-06-24
阅读全文2020-06-24
阅读全文2020-04-01
阅读全文2020-03-31